Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 10 of 25

TitlePrioritisation programmeDecisionDecision date
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]None selectedNot selected
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106None selectedNot selected
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]None selectedNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID12133]None selectedNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]None selectedNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353None selectedNot selected
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]None selectedNot selected
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]None selectedNot selected
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]None selectedn/a

Results per page

  1. 10
  2. 25
  3. 50
  4. All